Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients

scientific article published on August 14, 1975

Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF00562320
P953full work available at URLhttp://link.springer.com/article/10.1007/BF00562320/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF00562320
http://link.springer.com/content/pdf/10.1007/BF00562320.pdf
P698PubMed publication ID1233247

P2093author name stringM. Ehrnebo
I. Odar-Cederlöf
P2860cites workImmunochemical quantitation of antigens by single radial immunodiffusionQ28248574
Impairment of cognitive function associated with hydroxyamylobarbitone accumulation in patients with renal insufficiencyQ35174545
Anemia in uremia. Hemolysis evaluated by common methods and application of the bilirubin turnover methodQ45139788
Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein bindingQ47840215
The effect of bovine and human serum albumins on the mechanical properties of human erythrocyte membranesQ47965872
Determination of serum creatinine by a direct colorimetric methodQ48010258
Effects of psychotropic drugs on the erythrocyte permeability to glucose and ethylidene glucoseQ52733953
All lipid-soluble anaesthetics protect red cells.Q52737853
Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.Q53755058
The binding of indomethacin, salicylate and phenobarbitone to human whole blood in vitro.Q54586946
Complex formation between macromolecules and drugs. IX. The competition between two sulfa drugs and phenobarbital, pentobarbital or phenoxymethyl penicillin for binding sites on human serum albuminQ67273356
Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilutionQ68749158
Pentazocine binding to blood cells and plasma proteinsQ68794088
Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cellsQ69035464
The binding of phenothiazines to oxyhemoglobin A and SQ70035578
The Alteration of Plasma Proteins in Uremia as Reflected in their Ability to Bind Digitoxin and DiphenylhydantoinQ70440093
Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adultsQ70681355
Interindividual Differences in the Protein Binding of Sulfonamides: The Effect of Disease and Drugs 1,2Q71153617
The membrane concentraton of a local anesthetic (Chlorpromazine)Q72535769
THE IMPORTANCE OF BINDING TO ALBUMIN, BODY CELLS AND BACTERIA FOR PHARMACODYNAMICS AND EFFECT OF MEDICINAL SUBSTANCESQ76882624
RAPID PASSAGE OF ORGANIC ANIONS INTO HUMAN RED CELLSQ76943789
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
phenytoinQ410400
P304page(s)445-453
P577publication date1975-08-01
1975-08-14
P1433published inEuropean Journal of Clinical PharmacologyQ1376707
P1476titleBinding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients
P478volume8

Reverse relations

cites work (P2860)
Q72525469A Toxicological Evaluation of Different Adsorbents in Hemoperfusion
Q39631572A modified Sperber technique for direct estimation of true renal tubular excretion fraction
Q71295379Alteration of drug-protein binding in renal disease
Q40142216Anticonvulsant drugs. An update
Q39621414Binding of Drugs by Albumin Plasma Protein
Q39665699Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure
Q28543246Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy
Q26746873Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus
Q39281328Cyclobarbital as a test substance for oxidative drug metabolism in man. Findings in neuropsychiatric patients
Q37950599Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).
Q67541157Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: effect of salicylic acid, temperature and total drug concentration
Q34518414Diurnal variations in plasma diazepam concentrations associated with reciprocal changes in free fraction
Q70426620Drug distribution in whole blood of mothers and their newborn infants: studies of cloxacillin and flucloxacillin
Q39754383Free drug concentration monitoring in clinical practice. Rationale and current status
Q52618581Gentamicin and phenytoin sieving through hollow-fiber polysulfone hemofilters.
Q40148602Impaired Binding of Drugs and Endogenous Ligands in Renal Diseases
Q34621171Pethidine binding in whole blood: methodology and clinical significance
Q70540684Pethidine binding to blood cells and plasma proteins in old and young subjects
Q39228974Pharmaco-kinetic aspects of protein-binding (author's transl)
Q70087537Pharmacokinetics and distribution of flucloxacillin in pacemaker patients
Q69128799Pharmacokinetics of free and total flucloxacillin in newborn infants
Q70416631Pharmacokinetics of free and total sodium valproate in adolescents and young adults during maintenance therapy
Q40771925Plasma Protein Binding of Phenytoin and Warfarin in Patients Undergoing Renal Transplantation1
Q39851158Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats
Q53785712Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency.
Q39467922Salivary phenytoin concentrations in epilepsy and in chronic renal failure
Q71295407The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin
Q40640466The binding of drugs to plasma proteins from patients with poor renal function
Q67053866The clinical pharmacokinetics of phenytoin
Q41947254Variations in drug free fraction during alcohol withdrawal